BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 20730882)

  • 1. NOTCH1 mutation in a female with myeloid/NK cell precursor acute leukemia.
    Shiba N; Kanazawa T; Park MJ; Okuno H; Tamura K; Tsukada S; Hayashi Y; Arakawa H
    Pediatr Blood Cancer; 2010 Dec; 55(7):1406-9. PubMed ID: 20730882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloid/natural killer cell precursor acute leukemia with tetraploidy.
    Dinçol G; Palandüz S; Nalçaci M; Uçur A; Büyükaydin B
    Cancer Genet Cytogenet; 2005 Dec; 163(2):156-9. PubMed ID: 16337859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of NOTCH1 extracellular juxtamembrane expansion mutations in acute leukemias and multiple myelomas.
    Kim YR; Eom HS; Min CK; Lee S; Chung NG; Yoo NJ; Lee SH
    APMIS; 2009 Feb; 117(2):147-8. PubMed ID: 19239437
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of a child with myeloid/NK cell precursor acute leukemia with L-asparaginase and unrelated cord blood transplantation.
    Tezuka K; Nakayama H; Honda K; Suzumiya J; Oshima K; Kitoh T; Ishii E
    Int J Hematol; 2002 Feb; 75(2):201-6. PubMed ID: 11939270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-2 activated NK cell immunotherapy of three children after haploidentical stem cell transplantation.
    Koehl U; Sörensen J; Esser R; Zimmermann S; Grüttner HP; Tonn T; Seidl C; Seifried E; Klingebiel T; Schwabe D
    Blood Cells Mol Dis; 2004; 33(3):261-6. PubMed ID: 15528141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Graft-versus-leukemia effect by lymphocytes from the first donor after second cord blood transplantation in a patient with T-lymphoblastic lymphoma].
    Nagai K; Hashimoto H; Itoh K; Matsushita A; Shimoji S; Kimura T; Inoue D; Mori M; Nagai Y; Tabata S; Yanagida M; Takahashi T
    Rinsho Ketsueki; 2010 Jun; 51(6):413-21. PubMed ID: 20622488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of NOTCH1 mutations in adult T-cell leukemia/lymphoma and peripheral T-cell lymphoma.
    Shimizu D; Taki T; Utsunomiya A; Nakagawa H; Nomura K; Matsumoto Y; Nishida K; Horiike S; Taniwaki M
    Int J Hematol; 2007 Apr; 85(3):212-8. PubMed ID: 17483057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The beneficial role of inhibitory KIR genes of HLA class I NK epitopes in haploidentically mismatched stem cell allografts may be masked by residual donor-alloreactive T cells causing GVHD.
    Bishara A; De Santis D; Witt CC; Brautbar C; Christiansen FT; Or R; Nagler A; Slavin S
    Tissue Antigens; 2004 Mar; 63(3):204-11. PubMed ID: 14989709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alloreactive natural killer cells in mismatched hematopoietic stem cell transplantation.
    Ruggeri L; Capanni M; Mancusi A; Urbani E; Perruccio K; Burchielli E; Tosti A; Topini F; Aversa F; Martelli MF; Velardi A
    Blood Cells Mol Dis; 2004; 33(3):216-21. PubMed ID: 15528134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloid/NK cell precursor acute leukemia lost both CD13 and CD33 at first diagnosis.
    Ogura K; Kimura F; Kobayashi S; Torikai H; Ikeda T; Sato K; Motoyoshi K
    Leuk Res; 2006 Jun; 30(6):761-3. PubMed ID: 16140376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Successful treatment of myeloid/natural killer cell precursor acute leukemia with allogeneic peripheral blood stem cell transplantation].
    Shimokawa T; Saitoh M; Kojima Y; Takeyama H
    Rinsho Ketsueki; 2002 Feb; 43(2):112-6. PubMed ID: 11925873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myelodysplastic syndrome of donor origin subsequent to successful treatment of myeloid/NK-cell precursor leukaemia with allogeneic PBSCT: two very rare conditions in one patient.
    Beck C; Humpe A; Harder S; Schmid M; Horst HA
    Ann Hematol; 2005 Sep; 84(9):616-8. PubMed ID: 15782344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural killer cell allorecognition of missing self in allogeneic hematopoietic transplantation: a tool for immunotherapy of leukemia.
    Velardi A; Ruggeri L; Mancusi A; Aversa F; Christiansen FT
    Curr Opin Immunol; 2009 Oct; 21(5):525-30. PubMed ID: 19717293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ETV6-NCOA2: a novel fusion gene in acute leukemia associated with coexpression of T-lymphoid and myeloid markers and frequent NOTCH1 mutations.
    Strehl S; Nebral K; König M; Harbott J; Strobl H; Ratei R; Struski S; Bielorai B; Lessard M; Zimmermann M; Haas OA; Izraeli S
    Clin Cancer Res; 2008 Feb; 14(4):977-83. PubMed ID: 18281529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Secondary myeloid/natural killer cell acute leukemia appeared in multiple myeloma treated with melphalan].
    Kaya H; Nakamura S; Yamazaki H; Kumabashiri I; Ohtake S; Matsuda T
    Rinsho Ketsueki; 1995 Jul; 36(7):682-6. PubMed ID: 7563597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparable long-term survival after unrelated and HLA-matched sibling donor hematopoietic stem cell transplantations for acute leukemia in children younger than 18 months.
    Eapen M; Rubinstein P; Zhang MJ; Camitta BM; Stevens C; Cairo MS; Davies SM; Doyle JJ; Kurtzberg J; Pulsipher MA; Ortega JJ; Scaradavou A; Horowitz MM; Wagner JE
    J Clin Oncol; 2006 Jan; 24(1):145-51. PubMed ID: 16382124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered phenotype of natural killer cell subsets after haploidentical stem cell transplantation.
    Schulze A; Schirutschke H; Oelschlägel U; Schmitz M; Füssel M; Wassmuth R; Ehninger G; Bornhäuser M; Platzbecker U
    Exp Hematol; 2008 Apr; 36(4):378-89. PubMed ID: 18261840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy with donor leukocyte infusions for patients with relapsed acute myeloid leukemia following partially mismatched related donor bone marrow transplantation.
    Pati AR; Godder K; Lamb L; Gee A; Henslee-Downey PJ
    Bone Marrow Transplant; 1995 Jun; 15(6):979-81. PubMed ID: 7581101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Aggressive NK-cell leukemia with sustained relapse-free survival after allogeneic peripheral blood stem cell transplantation].
    Ino K; Masuya M; Nakamori Y; Suzuki K; Mizutani M; Sekine T; Yamaguchi M; Nakase K; Kaida K; Ogawa H; Katayama N
    Rinsho Ketsueki; 2010 Apr; 51(4):258-63. PubMed ID: 20467222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Successful treatment with idarubicin in a pediatric case of t(8;21) acute myelogenous leukemia with additional chromosomal abnormalities at relapse].
    Wakazono Y; Kataoka A; Fusaoka T; Tunamoto K
    Rinsho Ketsueki; 1998 Jul; 39(7):499-505. PubMed ID: 9750457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.